Literature DB >> 31486483

MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.

J Zheng1, Y Zhou, X-J Li, J-M Hu.   

Abstract

OBJECTIVE: The mortality rate of ovarian cancer (OC) has always been the highest among all female reproductive system malignant tumors. Currently, miRNAs have been verified to participate in the tumorigenesis and prognosis of OC. However, the expression and function of miR-574-3p in OC have not been fully elucidated. PATIENTS AND METHODS: The expression level of miR-574-3p in OC tissues and cells was detected using quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). By transfection of miR-574-3p mimics or inhibitor, the expression of miR-574-3p in SW626 or A2780 cells was up-regulated or down-regulated, respectively. Cell counting kit-8 (CCK-8) and colony formation assays were used to measure the proliferation of transfected OC cells. Meanwhile, the transwell assay was applied to detect the migration and invasion abilities of OC cells. Furthermore, dual-luciferase reporter gene analysis and Western blot were utilized to explore the underlying downstream molecules for miR-574-3p in OC.
RESULTS: MiR-574-3p was lowly expressed in OC tissue samples when compared with para-tumor tissues. Meanwhile, the expression of miR-574-3p in OC-derived cells was significantly lower than normal control HOSE cells. The overexpression of miR-574-3p markedly reduced the proliferation, invasion, and migration of SW626 cells. However, the inhibition of miR-574-3p remarkably accelerated the growth and metastasis of A2780 cells. MMP3 was verified as a direct target for miR-574-3p in OC. In addition, miR-574-3p could reduce the protein expression of MMP3 by binding to its 3'-untranslated region (3'-UTR).
CONCLUSIONS: MiR-574-3p functioned as a tumor suppressor in OC, which might be served as a potential target for the diagnosis and therapy for OC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31486483     DOI: 10.26355/eurrev_201908_18723

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  MicroRNA-574-3p Regulates HIF-α Isoforms Promoting Gastric Cancer Epithelial-Mesenchymal Transition via Targeting CUL2.

Authors:  Zhiwu Ji; Xingquan Wang; Yingli Liu; Min Zhong; Jiabin Sun; Jincai Shang
Journal:  Dig Dis Sci       Date:  2021-10-16       Impact factor: 3.487

2.  Samul-tang ameliorates oocyte damage due to cyclophosphamide-induced chronic ovarian dysfunction in mice.

Authors:  Jihyun Kim; Sooseong You
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

3.  MicroRNA-574 Impacts Granulosa Cell Estradiol Production via Targeting TIMP3 and ERK1/2 Signaling Pathway.

Authors:  Bo Pan; Xiaoshu Zhan; Julang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

4.  KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation data.

Authors:  Songling Zhu; Hongxia Bao; Meng-Chun Zhang; Huidi Liu; Yao Wang; Caiji Lin; Xingjuan Zhao; Shu-Lin Liu
Journal:  BMC Cancer       Date:  2022-06-16       Impact factor: 4.638

Review 5.  Matrix Metalloproteinase 3: A Promoting and Destabilizing Factor in the Pathogenesis of Disease and Cell Differentiation.

Authors:  Jiangtao Wan; Guowei Zhang; Xin Li; Xianshuai Qiu; Jun Ouyang; Jingxing Dai; Shaoxiong Min
Journal:  Front Physiol       Date:  2021-07-02       Impact factor: 4.566

6.  Circ-MFN2 Positively Regulates the Proliferation, Metastasis, and Radioresistance of Colorectal Cancer by Regulating the miR-574-3p/IGF1R Signaling Axis.

Authors:  Defeng Liu; Shihao Peng; Yangyang Li; Tao Guo
Journal:  Front Genet       Date:  2021-05-19       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.